Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by brutus2005on Jan 21, 2010 3:19pm
472 Views
Post# 16705080

RE: Level 2 update anyone?

RE: Level 2 update anyone?
STEM CELL THERP (SSS:TSX Venture)
Last: 0.37
Volume: 1,136,889
Quote as of: 21 Jan 2010 15:18 PM ET
Change: -0.015
Change (%): -3.90
Bid: 0.37
Ask: 0.375
Bid Size: 11
Ask Size: 22
Day High: 0.385
Day Low: 0.335
# Orders Shares Bid Ask Shares # Orders
1 5500 0.370 0.375 11000 1
1 10000 0.365 0.380 35500 4
8 33500 0.360 0.385 75500 7
1 10000 0.355 0.390 30000 2
4 73000 0.350 0.395 30000 2
Bullboard Posts